FDA Warns Against Splitting Tablets to Save Money

FDA Warns Against Splitting Tablets to Save Money
FDA Warns Against Splitting Tablets to Save Money

Splitting Tablets May Lead To Taking Too Much Medicine

While many consumers split pills in half in order to save money, even if the tablets are not scored down the middle, the FDA is warning against the practice as the dose in each half can vary significantly, potentially leading to taking too much medicine.

FDA researchers tested whether a score on a tablet impacted the uniformity of the dose in drugs, Norvasc (amlodipine), which is used to treat high blood pressure, and Neurontin (gabapentin), an anticonvulsant used to treat seizures.

Tablets were purchased from 5 amlodipine and 6 gabapentin drug manufacturers, Monthly Prescribing Reference reported. Both drugs are available as a generic.

When unscored amlodipine tablets were split, the variability in the dose of the two halves were significant. In addition, none of the split tablets met established criteria for “content uniformity.”

With gabapentin, the fully scored tablets met criteria for acceptable weight and dose of the active ingredient.

Overall, dividing tablets produced more variability in doses in both of the drugs, though the change in amolodipine was more significant.

The FDA warns against splitting tablets to save money, and in its own guidance, says that spiliting “can affect how much drug is present in the divide tablet and available for absorption.”

DISCLAIMER: MedShadow provides information and resources related to medications, their effects, and potential side effects. However, it is important to note that we are not a substitute for professional medical advice, diagnosis, or treatment. The content on our site is intended for educational and informational purposes only. Individuals dealing with medical conditions or symptoms should seek guidance from a licensed healthcare professional, such as a physician or pharmacist, who can provide personalized medical advice tailored to their specific circumstances.

While we strive to ensure the accuracy and reliability of the information presented on MedShadow, we cannot guarantee its completeness or suitability for any particular individual's medical needs. Therefore, we strongly encourage users to consult with qualified healthcare professionals regarding any health-related concerns or decisions. By accessing and using MedShadow, you acknowledge and agree that the information provided on the site is not a substitute for professional medical advice and that you should always consult with a qualified healthcare provider for any medical concerns.
Show Comments (0)
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Most Voted
Newest Oldest
Inline Feedbacks
View all comments